PHIO

#4758
Phio Pharmaceuticals Corp. Common Stock
1.2900 USD
+4.03%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
1.2900
1.2900
年范围
0.9780
1.3500
日变化
+4.03%
每月变动
+6.61%
6个月变化
+8.40%
年变化
+8.40%
前一天收盘价
1.2400
开盘价
1.2900
买价
卖价
最低价
1.2900
High
1.2900
交易量
3
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 14.9863 M
  • Employee 6
  • Founded 2011
  • CEO N/A
  • Website www.phiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG0024FKD97
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-0.72
市销率
—

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

新闻